z-logo
open-access-imgOpen Access
Octreotide modified PEGylated liposomes improved the anticancer efficacy of doxorubicin in somatostatin receptor II positive tumor model
Author(s) -
Jun-Lin Zhang,
Qiang Zhang
Publication year - 2010
Publication title -
journal of chinese pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 12
ISSN - 1003-1057
DOI - 10.5246/jcps.2010.05.050
Subject(s) - somatostatin receptor , liposome , doxorubicin , octreotide , pharmacology , chemistry , somatostatin receptor 2 , somatostatin , cancer research , medicine , chemotherapy , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here